Sian Bigora - 24 Jul 2025 Form 4/A - Amendment Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Chief Development Officer
Signature
/s/ Sian Bigora by John J. Wolfel, as Attorney-in-Fact
Issuer symbol
PCSA
Transactions as of
24 Jul 2025
Net transactions value
$0
Form type
4/A - Amendment
Filing time
18 Sep 2025, 16:13:49 UTC
Date Of Original Report
28 Jul 2025
Previous filing
11 Apr 2025
Next filing
03 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Bigora Sian Chief Development Officer C/O PROCESSA PHARMACEUTICALS, INC., 601 21ST STREET SUITE 300, VERO BEACH /s/ Sian Bigora by John J. Wolfel, as Attorney-in-Fact 18 Sep 2025 0001799365

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PCSA Common Stock 33,626 24 Jul 2025 Direct
holding PCSA Common Stock 6,668 24 Jul 2025 By CorLyst, LLC
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Amendment filed to retract the prior Form 4, which was filed in error.